The middle region of GLP-2 engages with TM1 and TM7 more extensively than with ECL2, and the GLP-2 C-terminus closely attaches to ECL1, which is the most protruded among 9 class B G protein-coupled receptors (GPCRs)
By weeks 48 at a stable dose, the majority of users adapt and symptoms either disappear or become consistently mild
Symptoms include chronic nausea, vomiting, bloating, and malnutrition
Zaccardi F, Jacquot E, Cortese V, Tyrer F, Seidu S, Davies MJ, Khunti K
On-going support Access expert guidance, answers, and continuous care100% online, whenever you need it
We simply try to be thoughtful about the kind of risk were taking, and that one, we just cant find an asset that makes sense for us.